Office of Commercialization and Economic Development
Office of Technology Commercialization

Mouse: Human ACE2 Expression

Technology #20-0133

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Ralph Baric
Managed By
Tangible Property

Angiotensin converting enzyme 2 (ACE2) is the cellular entry receptor for many SARS-like coronaviruses. SARS-CoV and SARS-CoV-2 bind and enter human cells via the ACE2 receptor.  This mouse line expresses human ACE2 under the control of HFH4, a lung ciliated epithelial promoter. HFH4-hACE2-expressing mice are sensitized to infection by SARS-like coronaviruses when compared with wild-type mice. Wild-type mice do not develop clinical disease, however, this mouse strain was developed to express human ACE2 which allows for testing in mice that develop clinical disease upon infection. When infected with SARS-CoV Urbani, HFH4-hACE2-expressing mice experienced no weight loss for the first 3 days, but then experienced rapid weight loss and death between days 4 and 5. This mouse line shows value as a model to study coronavirus pathogenesis and to test therapeutic and vaccine efficacy against such coronaviruses.
This research tool is available from the Mutant Mouse Resource and Research Center (MMRRC) at the following link:

Related Publications:

blank”>SARS-like WIV1-CoV poised for human emergencePNAS March 15, 2016 113 (11) 3048-3053.